title: Is the literature inconclusive about the harm from HES? Yes.
authors.affiliation: Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital of Muenster, Albert-Schweitzer-Campus 1, Bld. A1, 48149, Muenster, Germany. ertmer@anit.uni-muenster.de.
authors.forename: Christian
authors.initials: C
authors.lastname: Ertmer
authors.affiliation: General ICU, Raymond Poincaré Hospital (APHP), Laboratory of Inflammation and Infection U1173 INSERM and University of Versailles SQY, 104 Boulevard Raymond Poincaré, 92380, Garches, France.
authors.forename: Djillali
authors.initials: D
authors.lastname: Annane
authors.affiliation: Department of Anaesthesiology Centr-hospitalo-universitaire Brugmann, Universite Libre de Bruxelles, Brussels, Belgium.
authors.forename: Philippe
authors.initials: P
authors.lastname: Van Der Linden
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D016638:Critical Illness / Q000401:mortality* / Q000628:therapy; D000077324:Crystalloid Solutions; D005440:Fluid Therapy / Q000009:adverse effects / Q000379:methods; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects* / Q000494:pharmacology; D007552:Isotonic Solutions / Q000008:administration & dosage; D015201:Meta-Analysis as Topic; D010952:Plasma Substitutes / Q000009:adverse effects* / Q000493:pharmacokinetics; D012307:Risk Factors
chemical_list: D000077324:Crystalloid Solutions; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D010952:Plasma Substitutes